Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease: Past, Present, and Future
Monoamine oxidase-B (MAO-B) inhibitors are commonly used for the symptomatic treatment of Parkinson’s disease (PD). MAO-B inhibitor monotherapy has been shown to be effective and safe for the treatment of early-stage PD, while MAO-B inhibitors as adjuvant drugs have been widely applied for the treat...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2022-02-01
|
| Col·lecció: | Journal of Parkinson’s Disease |
| Accés en línia: | https://doi.org/10.3233/JPD-212976 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|